DKMA Update October 2017
10 October 2017
In this issue of DKMA Update, you can read about the decision to change the dispensing status of a number of opioids, about the new guidelines on medicinal cannabis for doctors, and about the executive order on the import of cannabis products.
This newsletter features the following articles:
- T cells – new perspectives in cancer treatment
- More opioids subject to stricter monitoring (dispensing status A§4)
- Medicinal cannabis – new products, new rules and new guidelines
- New 9-valent HPV vaccine in the childhood immunisation programme
- The DKMA is expanding and recruiting new employees
- New report on biological medicines and biosimilars
- Global operation against illegal medicines
- Most recent Direct Healthcare Professional Communications (DHPCs)